Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Toxicology and Applied Pharmacology
|
March 28, 2026
Camizestrant-induced heart rate reduction is mediated via a sinoatrial node pacemaker channel mechanism
Andrew Hall, Saïd El-Haou, Inmaculada C Villar, et al.
Journal of Pharmacological and Toxicological Methods
|
June 21, 2025
Current practices on the measurement of electrocardiogram and hemodynamic parameters in non-rodent species in regulatory safety assessment studies
Jean-Pierre Valentin, Todd Bourcier, Xuan Chi, et al.
Journal of Medicinal Chemistry
|
March 19, 2024
Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure
Kenneth L Granberg, Shigeki Sakamaki, Niklas Larsson, et al.
Journal of Medicinal Chemistry
|
July 11, 2026
TRPV4: A Promising Therapeutic Target Ion Channel─Discovery of Ultrapotent Selective Antagonists
Magnus Nilsson, Sara J Bonvini, Emelyne Diers, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Toxicology and Applied Pharmacology
|
March 28, 2026
Camizestrant-induced heart rate reduction is mediated via a sinoatrial node pacemaker channel mechanism
Andrew Hall, Saïd El-Haou, Inmaculada C Villar, et al.
Journal of Pharmacological and Toxicological Methods
|
June 21, 2025
Current practices on the measurement of electrocardiogram and hemodynamic parameters in non-rodent species in regulatory safety assessment studies
Jean-Pierre Valentin, Todd Bourcier, Xuan Chi, et al.
Journal of Medicinal Chemistry
|
March 19, 2024
Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure
Kenneth L Granberg, Shigeki Sakamaki, Niklas Larsson, et al.
Journal of Medicinal Chemistry
|
July 11, 2026
TRPV4: A Promising Therapeutic Target Ion Channel─Discovery of Ultrapotent Selective Antagonists
Magnus Nilsson, Sara J Bonvini, Emelyne Diers, et al.
Page
of 2